BioSig Technologies, Debt
| BSGM Stock | USD 1.34 0.04 3.08% |
BioSig Technologies, holds a debt-to-equity ratio of 0.454. . BioSig Technologies,'s financial risk is the risk to BioSig Technologies, stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
BioSig Technologies,'s liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. BioSig Technologies,'s cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the OTC Stock is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps BioSig OTC Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect BioSig Technologies,'s stakeholders.
For most companies, including BioSig Technologies,, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for BioSig Technologies, Common, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, BioSig Technologies,'s management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that BioSig Technologies,'s debt-to-equity ratio measures a OTC Stock's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which BioSig Technologies, is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of BioSig Technologies, to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, BioSig Technologies, is said to be less leveraged. If creditors hold a majority of BioSig Technologies,'s assets, the OTC Stock is said to be highly leveraged.
BioSig |
BioSig Technologies, Debt to Cash Allocation
Many companies such as BioSig Technologies,, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
BioSig Technologies, Common currently holds 452 K in liabilities with Debt to Equity (D/E) ratio of 0.45, which is about average as compared to similar companies. BioSig Technologies, has a current ratio of 1.2, suggesting that it is in a questionable position to pay out its financial obligations when due. Debt can assist BioSig Technologies, until it has trouble settling it off, either with new capital or with free cash flow. So, BioSig Technologies,'s shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioSig Technologies, sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioSig to invest in growth at high rates of return. When we think about BioSig Technologies,'s use of debt, we should always consider it together with cash and equity.BioSig Technologies, Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the BioSig Technologies,'s operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of BioSig Technologies,, which in turn will lower the firm's financial flexibility.BioSig Technologies, Corporate Bonds Issued
Understaning BioSig Technologies, Use of Financial Leverage
Leverage ratios show BioSig Technologies,'s total debt position, including all outstanding obligations. In simple terms, high financial leverage means that the cost of production, along with the day-to-day running of the business, is high. Conversely, lower financial leverage implies lower fixed cost investment in the business, which is generally considered a good sign by investors. The degree of BioSig Technologies,'s financial leverage can be measured in several ways, including ratios such as the debt-to-equity ratio (total debt / total equity), or the debt ratio (total debt / total assets).
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. Biosig Technologies operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 50 people. Please read more on our technical analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in BioSig OTC Stock
BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.